Mini Nicotine Lozenge
Product Images NDC 68016-087

1 FDA label image from Chain Drug Consortium, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mini Nicotine (NDC 68016-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Consortium, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Polacrilex 4 mg (Nicotine 4 mg Mini Mint Lozenge 1)

Nicotine Polacrilex 4 mg (Nicotine 4 mg Mini Mint Lozenge 1)
Drug Facts and product information for Mini Nicotine Lozenges 4 mg (nicotine polacrilex) include active ingredient, purpose, uses, warnings, directions, and other information such as inactive ingredients, storage, and a helpline. Directions emphasize use by adults and proper dosing schedules for quitting smoking. Additional instructions appear for opening and increasing quitting success, including use with a support program. The label also notes the product is not for sale to those under 18 years of age.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.